4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-25-017223
Chief Executive Officer acquired 66,667 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Fried Robert N · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-09 | Exercise or conversion : show line 1 in the form | +66,667 | $3.30 | $220,001 | 1,038,981 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-04-09 | Exercise or conversion : show line 2 in the form Stock Options (right to buy) | −66,667 | 0 | D |
Loading xslF345X05/wk-form4_1744242755.xml…